SCHEMBL22978715

SCHEMBL22978715

CC(C)CC(=O)OC(=O)N1CCCCC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.39
POLB P06746 2/20 0.39
HPGD P15428 3/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
MMP1 P03956 2/20 0.36
MMP2 P08253 2/20 0.36
MMP8 P22894 1/20 0.36
MMP3 P08254 1/20 0.35
MMP9 P14780 1/20 0.35
MMP13 P45452 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
HSD11B1 P28845 1/20 0.35
CYP2D6 P10635 1/20 0.35
NPC1 O15118 1/20 0.35
MAPT P10636 1/20 0.35
HTT P42858 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28771185 0.80 ALDH1A1 (0.44) ALDH1A1POLBHPGDMEN1KMT2A
SCHEMBL28771501 0.78 ALDH1A1 (0.41) ALDH1A1POLBHPGDMEN1KMT2A
SCHEMBL20600234 0.76 ALDH1A1 (0.40) ALDH1A1POLBHPGDMEN1KMT2A
SCHEMBL20599579 0.76 ALDH1A1 (0.40) ALDH1A1POLBHPGDMEN1KMT2A
SCHEMBL6697255 0.75 ALDH1A1 (0.50) ALDH1A1POLBHPGDMEN1KMT2A
SCHEMBL4728435 0.75 ALDH1A1 (0.33) ALDH1A1POLBHSD11B1SMN1; SMN2
SCHEMBL30443406 0.75 ALDH1A1 (0.54) ALDH1A1POLBHPGDMEN1KMT2A
SCHEMBL3740475 0.74 POLB (0.58) ALDH1A1POLBMEN1KMT2ANPSR1
SCHEMBL8250570 0.74 POLB (0.58) ALDH1A1POLBMEN1KMT2ANPSR1
SCHEMBL20599636 0.73 MGAM (0.38) ALDH1A1POLBHPGDL3MBTL1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021026803-A1 PIPERIDINYL-METHYL-PURINEAMINES AS NSD2 INHIBITORS AND ANTI-CANCER AGENTS NOVARTIS AG (CH) 2021-02-18 WO disclosed